 The Money Times | <img alt="" height="1" width="1" />Salix shares up after FDA clears liver disorder drugReuters"Attention will quickly turn to the late-stage trial data for Xifaxan in IBS, a much larger commercial opportunity," Jefferies & Co analyst Davis said. ...Piper Jaffray Reiterates Salix Pharmaceuticals (SLXP) Overweight Rating<nobr>Benzinga</nobr>Salix Soars on FDA Approval of Xifaxan for Liver Ailment; Eyed for Irritable ...<nobr>ONN.tv</nobr>Salix shares surge on Xifaxan approval<nobr>FierceBiotech</nobr><nobr>BusinessWeek</nobr> -<nobr>News & Observer</nobr> -<nobr>Trading Markets (press release)</nobr><nobr>all 109 news articles »</nobr> |
Google- Salix shares up after FDA clears liver disorder drug - Reuters
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!